Trevor Brasel, PhD

For the past decade, Dr. Brasel has focused on the development and evaluation of medical countermeasures, including vaccines, for emerging and biological defense-related infectious diseases. He has played key roles in the advancement of vaccine candidates against plague, anthrax, tularemia, smallpox, and most recently, hemorrhagic fevers caused by Ebola and Marburg viruses. Throughout his career, Dr. Brasel has focused on advanced product development under the United States Food and Drug Administration (FDA) Animal Rule (21 CFR 601.90) which allows efficacy findings from adequate and well-controlled animal studies to be used in cases where it is not feasible or ethical to conduct trials in humans.

Search PubMed for Dr. Brasel's publications

SIVS 150x100 logo